Clinical Trial Update: Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing drug–drug interactions between ivacaftor (VX-770) and midazolam/rosiglitazone, and the impact of fluconazole on ivacaftor in cystic fibr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Avandia (rosiglitazone)
• Diflucan (Fluconazole)
• Kalydeco (ivacaftor)
• Versed (Midazolam)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED